Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
Titel:
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
Auteur:
Verbrugge, Sue Ellen Al, Marjon Assaraf, Yehuda G Niewerth, Denise van Meerloo, Johan Cloos, Jacqueline van der Veer, Michael Scheffer, George L Peters, Godefridus J Chan, Elena T Anderl, Janet L Kirk, Christopher J Zweegman, Sonja Dijkmans, Ben AC Lems, Willem F Scheper, Rik J de Gruijl, Tanja D Jansen, Gerrit